Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

Sudden blast phase in paediatric chronic myeloid leukemia-chronic phase with abnormal blasts detected by flow cytometry at diagnosis. Can it be considered a warning sign? (Vijayasekharan K et al. Cytometry B Clin Cymtom, May 2021)

Sudden blast phase in paediatric chronic myeloid leukemia-chronic phase with abnormal blasts detected by flow cytometry at diagnosis. Can it be considered a warning sign?
Vijayasekharan K et al. Cytometry B Clin Cytom, May 2021

Link to full abstract

 

 

Tyrosine kinase inhibitors and beyond for chronic myeloid leukemia in children (Phillips LN and Hijiya N. Paediatr Drug, April 2021)

Tyrosine kinase inhibitors and beyond for chronic myeloid leukemia in children
Phillips LN and Hijiya N. Paediatr Drug, April 2021 (epub ahead of print)

Link to full abstract

 


 

Chronic myelogenous leukemia in childhood (Smith SM et al. Curr Oncol Rep, March 2021)

Chronic myelogenous leukemia in childhood
Smith SM et al. Curr Oncol Rep, March 2021

Link to full abstract

 


 

Paediatric chronic myeloid leukemia presenting in de novo or secondary blast phase – a comparison of clinical and genetic characteristics (Sembill S et al. Br J Haematol, March 2021)

Paediatric chronic myeloid leukemia presenting in de novo or secondary blast phase – a comparison of clinical and genetic characteristics
Sembill S et al. Br J Haematol, March 2021 (epub ahead of print) - open access publication

Link to full abstract

 


 

Definition, epidemiology, pathophysiology, and essential criteria for diagnosis of pediatric chronic myeloid leukemia (Suttorp M et al. Cancers(Basel), February 2021)

Definition, epidemiology, pathophysiology, and essential criteria for diagnosis of pediatric chronic myeloid leukemia
Suttorp M et al. Cancers(Basel), February 2021 - open access publication

Link to full abstract

 


 

  1. Long-term safety and efficacy of imatinib in pediatric patients with chronic myeloid leukemia: Single-Center experience from China (Cai Y et al. Int J Hematol, January 2021)
  2. Successful haploidentical stem cell transplant with posttransplant cyclophosphamide for isolated central nervous system blast crisis in a child with CML (Chatterjee G et al. J Pediatr Hematol Oncol, January 2021)
  3. Factors and outcomes of chronic myeloid leukemia at very young age: Data from the International Pediatric Chronic Myeloid Leukemia Registry (Meral Günes A et al. Pediatr Blood Cancer, October 2020)
  4. Lymphoblastic predominance of blastic phase in children with chronic myeloid leukemia treated with imatinib: A report from the I-CML-Ped Study (Meyran D et al. Eur J Cancer, August 2020)